BetterLife Pharma (BETRF) Total Debt (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Total Debt of $1.2 million for Q2 2026, up 97.32% year-over-year from $610757.0 in Q2 2025, and up 12.29% quarter-over-quarter from $1.1 million in Q1 2026.
BetterLife Pharma (BETRF) Total Debt (2011 - 2026) Analysis & Trends
BetterLife Pharma's Total Debt history runs 16 years deep, the most recent figure standing at $1.2 million for Q2 2026.
- In Q2 2026, Total Debt rose 97.32% year-over-year to $1.2 million; the TTM figure through Apr 2026 stood at $1.2 million (up 97.32% YoY), while the FY2026 annual figure was $1.1 million, up 2943.86% from the prior year.
- Total Debt for Q2 2026 stood at $1.2 million, up from $1.1 million in the prior quarter.
- The five-year high for Total Debt was $5.6 million in Q1 2024, with the low at $35258.0 in Q1 2025.
- The 5-year median for Total Debt is $725847.2 (2025), against an average of $1.3 million.
- The sharpest annual moves came in 2025 and 2026: Total Debt tumbled 99.37% in 2025, then jumped 2943.86% in 2026.
- BetterLife Pharma's Total Debt stood at $584189.6 in 2022, then soared by 31.22% to $766544.5 in 2023, then climbed by 15.92% to $888589.9 in 2024, then decreased by 18.31% to $725847.2 in 2025, then surged by 66.03% to $1.2 million in 2026.
- Business Quant data shows BETRF's Total Debt at $1.2 million in Q2 2026, $1.1 million in Q1 2026, and $725847.2 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 115,555.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.21 Mn |
| Jan 31, 2026 | 1.07 Mn |
| Jul 31, 2025 | 725,847.24 |
| Apr 30, 2025 | 610,756.96 |
| Jan 31, 2025 | 35,257.97 |
| Oct 31, 2024 | 888,589.87 |
| Jul 31, 2024 | 710,971.85 |
| Apr 30, 2024 | 954,430.15 |
| Jan 31, 2024 | 5.63 Mn |
| Oct 31, 2023 | 766,544.51 |
| Jul 31, 2023 | 619,599.79 |
| Apr 30, 2023 | 520,278.80 |
| Jan 31, 2023 | 5.57 Mn |
| Oct 31, 2022 | 584,189.63 |
| Jul 31, 2022 | 387,616.71 |
| Apr 30, 2022 | 289,275.63 |
| Jan 31, 2022 | 797,494.18 |
| Oct 31, 2021 | 163,746.43 |
| Jul 31, 2021 | 311,861.32 |
| Apr 30, 2021 | 520,123.50 |